SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-11-011810
Filing Date
2011-03-01
Accepted
2011-03-01 10:49:22
Documents
2
Period of Report
2011-02-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v213109_8k.htm 8-K 29170
2 v213109_ex99-1.htm EX-99.1 16221
  Complete submission text file 0001144204-11-011810.txt   47149
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10019
Business Address 110 EAST 59TH STREET NEW YORK NY 10019 250-519-0553
BRAINSTORM CELL THERAPEUTICS INC (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 912061050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-61610 | Film No.: 11649547
SIC: 2836 Biological Products, (No Diagnostic Substances)